{"id":565443,"date":"2026-09-06T20:00:00","date_gmt":"2026-09-06T18:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/los-productos-biologicos-los-nuevos-en-el-mercado\/"},"modified":"2026-09-11T17:46:44","modified_gmt":"2026-09-11T15:46:44","slug":"los-productos-biologicos-los-nuevos-en-el-mercado","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/los-productos-biologicos-los-nuevos-en-el-mercado\/","title":{"rendered":"Los productos biol\u00f3gicos, los \u00abnuevos en el mercado\u00bb"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Lo que hace unos a\u00f1os supuso un cambio de paradigma en el asma grave, se est\u00e1 introduciendo ahora tambi\u00e9n en el tratamiento de la EPOC: la terapia con anticuerpos espec\u00edfica para cada fenotipo. Los principales candidatos para el uso de f\u00e1rmacos biol\u00f3gicos son los pacientes con EPOC grave que, a pesar de recibir una terapia triple (LABA + LAMA + ICS), siguen padeciendo exacerbaciones recurrentes. Con el dupilumab y el mepolizumab, ya son dos los anticuerpos monoclonales de gran eficacia que han obtenido la autorizaci\u00f3n de Swissmedic para la indicaci\u00f3n de la EPOC.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Flos-productos-biologicos-los-nuevos-en-el-mercado%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Lo que hace unos a\u00f1os supuso un cambio de paradigma en el asma grave, se est\u00e1 introduciendo ahora tambi\u00e9n en el tratamiento de la EPOC: la terapia con anticuerpos espec\u00edfica&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Flos-productos-biologicos-los-nuevos-en-el-mercado%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":565444,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"EPOC: intensificaci\u00f3n del tratamiento basada en biomarcadores  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11552,11483,11408,11288,11424],"tags":[12425,100794,100791,13573,16249,12125,13813,100790,13812,21155,100797,27566,100796,100795,100792,100793,27569,59241,22688],"powerkit_post_featured":[],"class_list":["post-565443","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-el-congreso-informa","category-farmacologia-y-toxicologia","category-medicina-interna-general","category-neumologia","tag-biologicos-es","tag-boreas","tag-clasificacion-abe","tag-dupilumab-es","tag-dupixent-es","tag-epoc","tag-ics-es","tag-intensificacion-del-tratamiento-basada-en-biomarcadores","tag-laba-es","tag-lama-es","tag-matinee","tag-mepolizumab-es","tag-metreo","tag-metrex","tag-niveles-de-eosinofilos","tag-notus","tag-nucala-es","tag-terapia-con-anticuerpos","tag-terapia-triple","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-18 19:23:06","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/565443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=565443"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/565443\/revisions"}],"predecessor-version":[{"id":565445,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/565443\/revisions\/565445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/565444"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=565443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=565443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=565443"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=565443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}